Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

By sjmartinez • November 19, 2024

Abdel Jawad M, Spertus JA, Ikeaba U, Greene SJ, Fonarow GC, Chiswell K, Chan PS. Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction. JAMA Cardiol. 2024 Nov 18:e244489. doi: 10.1001/jamacardio.2024.4489. Epub ahead of print. PMID: 39556474; PMCID: PMC11574726.

Tags: Cardiology/Epi, Publications

Outcome of Patients Presenting With High-Risk Pulmonary Embolism Treated With Mechanical Thrombectomy: A Subgroup Analysis From the STRIKE-PE Study

Sharp ASP, Dohad SY, Weinberg I, Kurzyna M, Davis HC, Stepniewski J, Perkowski PE, Holden A, West FM, Keeling WB, Parikh SA, Moriarty JM. Outcome[...]

Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of Hepatic Encephalopathy in Cirrhosis

Singh V, Wang M, Ebinger J, Velazquez A, Cheng S, Kwan AC, Trivedi HD. Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of[...]

Temporal Trends and Future Projections of Pulmonary Embolism and Top Contributing Causes of death in the United States, 1968-2040: insights from the CDC WONDER database

Khan S, Abbas F, Hassan M, Hussain M, Ahmed M, Ahsan A, Qureshi S, Khalid N, Sajjad A, Baig M, Waqas SA, Fonarow GC, Greene[...]